Cellectis S.A. (EPA:ALCLS)
2.490
+0.180 (7.79%)
Aug 1, 2025, 5:35 PM CET
Exscientia Revenue
Cellectis had revenue of $12.03M USD in the quarter ending March 31, 2025, with 85.10% growth. This brings the company's revenue in the last twelve months to $54.75M, up 351.26% year-over-year. In the year 2024, Cellectis had annual revenue of $49.22M with 435.37% growth.
Revenue (ttm)
$54.75M
Revenue Growth
+351.26%
P/S Ratio
3.55
Revenue / Employee
$246.61K
Employees
222
Market Cap
180.00M
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49.22M | 40.02M | 435.37% |
Dec 31, 2023 | 9.19M | -16.53M | -64.26% |
Dec 31, 2022 | 25.72M | -12.87M | -33.35% |
Dec 31, 2021 | 38.60M | -20.97M | -35.20% |
Dec 31, 2020 | 59.56M | 36.57M | 159.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 10.59M |
Virbac | 1.40B |
Cellectis News
- 1 day ago - Cellectis Q2 2025 Earnings Preview - Seeking Alpha
- 5 days ago - Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025 - GlobeNewsWire
- 4 weeks ago - Cellectis files $200M mixed shelf offering - Seeking Alpha
- 5 weeks ago - Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025 - GlobeNewsWire
- 2 months ago - Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025 - GlobeNewsWire
- 2 months ago - Cellectis: Partnerships And Promised Data In 2025 Continue To Justify The Buy - Seeking Alpha
- 2 months ago - Cellectis Non-GAAP EPS of -$0.17, revenue of $12M misses by $1.83M - Seeking Alpha
- 2 months ago - Cellectis Reports Financial Results for the First Quarter 2025 - GlobeNewsWire